Investigation of Effects of Delayed Feedback on Non-motor Symptoms in Individuals With Parkinson's Disease Trial N/A Completed Sept. 4, 2025
Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease Trial Phase 1 Recruiting Sept. 4, 2025
Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study) Trial Phase 1 Recruiting Sept. 4, 2025
A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants Trial Phase 1 Completed Sept. 4, 2025
The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes Trial Phase 2 Recruiting Sept. 4, 2025
Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status Trial N/A Active, not recruiting Sept. 3, 2025
Microbiota Intervention to Change the Response of Parkinson's Disease Trial Phase 1 Suspended Sept. 3, 2025
Technology Assisted Nudging to Increase Physical Activity Among Hospitalised Medical Patients Trial N/A Completed Sept. 3, 2025
Study of Clonidine Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease: Trial Phase 2 Completed Sept. 2, 2025
Cognitive, Affective, and Motor Effects of Tangotherapy in Parkinson's Disease Trial N/A Completed Sept. 2, 2025
Pathophysiology and pharmacological management for sleep problems in Parkinson's disease News SAGE Publications: Journal of Parkinson’s Disease: Table of Contents Sept. 2, 2025
Examining the Validity and Reliability of the Dresden Falls Questionnaire in Patients With Parkinson's Diagnosis Living in Turkey Trial N/A Completed Sept. 1, 2025